ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1237 • 2017 ACR/ARHP Annual Meeting

    Group Strength Training in Rheumatology Patients: Results of an Exercise Survey

    Kevin Rhie1, Danielle Feger2, Sharon Banks2, Christopher Sciamanna3 and Rayford R. June4, 1Internal Medicine, Penn State Hershey Medical Center, Hershey, PA, 2Medicine/Rheumatology, Penn State College of Medicine, Hershey, PA, 3Medicine/Division of Population Health Research and Development, Penn State College of Medicine, Hershey, PA, 4Rheumatology, Penn State Hershey Medical Center, Hershey, PA

    Background/Purpose: Primary care (PC) patients have shown significant interest in a community based group strength training (GST) program, especially among those in poor health1. Exercise…
  • Abstract Number: 1238 • 2017 ACR/ARHP Annual Meeting

    The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity

    Anca Askanase1, Samantha Nguyen2, Miya Okado2, Nancy Leidy3 and Joan T. Merrill4, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 3Evidera, Bethesda, MD, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: The LFA REALTM is designed as two complimentary disease activity measures in order to integrate clinician and patient input. The current report updates progress…
  • Abstract Number: 1239 • 2017 ACR/ARHP Annual Meeting

    Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients

    Meenakshi Jolly1, Aman Kugasia2, Carlos Cordova3, Joshlean Fair3, Eleftheria Steinig4, Rasa Kazkauskaite5, Lisa Walt6, Mondira Sengupta7 and Joel A. Block2, 1Rush, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rheumatology, Rush University Medical Center, Chicago, IL, 4Northwestern Univeristy, Chicago, IL, 5Rush University, chicago, IL, 6American Hospital Association, Chicago, IL, 7John H Stroger Hospital of Cook County, Chicago, IL

    Background/Purpose: The major cause of mortality in patients with Rheumatoid Arthritis (RA) is cardiovascular disease (CVD). However traditionally, very few RA patients receive screening and…
  • Abstract Number: 1240 • 2017 ACR/ARHP Annual Meeting

    Active Disease Is Associated with Dependency in Inflammatory Arthritis

    Havva Ozturk Durmaz1, Alper Sari2, Berkan Armagan2, Abdulsamet Erden3, Levent Kilic2, Omer Karadag4, Sedat Kiraz2, Sule Apras Bilgen3 and Umut Kalyoncu3, 1Physical Medicine and Rehabilitation, Ahi Evran University Faculty of Medicine, Kırsehir, Turkey, 2Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Department of Internal Medicine, Divison of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: The independency is one of the major concerns according to patients' perspective. For instance, independency is top ranking problem in psoriatic arthritis patients and…
  • Abstract Number: 1241 • 2017 ACR/ARHP Annual Meeting

    Understanding Differences in Patient Definitions of RA Flares Using Omeract Core Domains

    Gabriela L. Maica1, Michelle Frits2, Christine Iannaccone3, Taysir G. Mahmoud4, Clifton O. Bingham III5, Vivian P. Bykerk6, Michael Weinblatt7 and Nancy A. Shadick8, 1Department of Rheumatology, Allergy, and Immunology, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Rheumatology, Johns Hopkins University, Baltimore, MD, 62-005, Mt Sinai Hospital, Toronto, ON, Canada, 7Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Flare is an important, distinct feature of RA, often rendering patients immobile and contributing to a poor quality of life. Recently, there has been…
  • Abstract Number: 1242 • 2017 ACR/ARHP Annual Meeting

    Impact of Social Support and Illness Perception on the Transition of Pediatric SLE Patients to Adult Care

    Mary Beth Son1, David Zurakowski2, David J. Kreps3, Siobhan Case4 and Karen H. Costenbader3, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Departments of Anesthesia and Surgery, Boston Children’s Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Boston Children's Hospital, Boston, MA

    Background/Purpose : We surveyed adult patients with a history of pediatric systemic lupus erythematosus (pSLE) regarding their process of transition from pediatric to adult care…
  • Abstract Number: 1243 • 2017 ACR/ARHP Annual Meeting

    Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach

    Jerik Leung1, Deepali Sen2 and Alfred Kim3, 1Internal Medicine/Rheumatology, Washington University School of Medicine, Saint Louis, MO, 2Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, 3IM/Rheumatology, Washington University School of Medicine, St. Louis, MO

    Background/Purpose: The patient-specific experience of living with SLE is underreported. While there are data addressing factors influencing the quality of life of patients with SLE,…
  • Abstract Number: 1244 • 2017 ACR/ARHP Annual Meeting

    Are Chinese-American Rheumatology Patients Who Use Traditional Chinese Medicine Less Adherent to Prescribed Western Medications?

    Kai Sun1, Jackie Szymonifka2, Henghe Tian3, Ya Ju Chang4, Jennifer Leng5 and Lisa A. Mandl6, 1Hospital for Special Surgery/Weill Cornell medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Internal Medicine, New York University School of Medicine, New York, NY, 4Mount Sinai Beth Israel, New York, NY, 5Immigrant Health and Cancer Disparities laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 6Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: High adherence is crucial for the management of rheumatic diseases. Nonadherence is more common among immigrants and minorities and may contribute to known outcome…
  • Abstract Number: 1245 • 2017 ACR/ARHP Annual Meeting

    Transition in Work Status and Quality of Life in People with Inflammatory Arthritis

    Wiebke Bartels1, Eric C. Sayre2, Pam Rogers3 and Diane Lacaille4, 1Science, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, 4University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada

     Background/Purpose: People with inflammatory arthritis (IA) frequently have to stop working due to their arthritis. It is assumed that economic and psychosocial consequences of premature…
  • Abstract Number: 1246 • 2017 ACR/ARHP Annual Meeting

    Patient Preferences Associated with the Use of Treatments for Psoriatic Arthritis: Results of a Conjoint Analysis

    Yihua Xu1, Lavanya Sudharshan1, Ming-Ann Hsu2, Andrew Koenig3, Joseph C Cappelleri4, Wen Liu5, Tim Smith6 and Margaret Pasquale1, 1Comprehensive Health Insights Inc., Louisville, KY, 2Pfizer Inc, Groton, CT, 3Pfizer Inc, Collegeville, PA, 4Statistics, Pfizer Inc, New London, CT, 5Humana Inc., Louisville, KY, 6Pfizer Inc, New York, NY

    Background/Purpose: As Psoriatic Arthritis (PsA) treatment choices continue to expand, it is important to consider patient preferences for treatment modalities for PsA. Involving patients in…
  • Abstract Number: 1247 • 2017 ACR/ARHP Annual Meeting

    Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression

    Dylan Ruebeck1, Judith Baumhauer2 and Allen P. Anandarajah3, 1Internal Medicine, University of Rochester Medical Center, Rochester, NY, 2Orthopedics, University of Rochester Medical Center, rochester, NY, 3Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY

    Background/Purpose: Quality of life (QOL) measures as assessed by Patient Reported Outcome Measurement Information System (PROMIS) can contribute essential information about the status of or…
  • Abstract Number: 1248 • 2017 ACR/ARHP Annual Meeting

    Evaluation of Validated Patient Reported Outcome Measures to Assess Sensitivity to Change in Patients with Systemic Sclerosis and Gastroesophageal Reflux Disease —a Scleroderma Clinical Trials Consortium Collaborative Project

    Zsuzsanna McMahan1, Tracy M. Frech2, David Lim3, Veronica J. Berrocal4, Cosimo Bruni5, Marco Matucci-Cerinic6, Vanessa Smith7, Karin Melsons8, Susanna Proudman9, Jinyu Zhang10, Fabian A Mendoza11, Melanie Woods3 and Dinesh Khanna3, 1Department of Internal Medicine, Johns Hopkins University, Baltimore, MD, 2Division of Rheumatology, University of Utah, Salt Lake City, UT, 3University of Michigan, Ann Arbor, MI, 4Div of Rheumatology, University of Michigan, Ann Arbor, MI, 5Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy, 6Dept of Medicine/Div of Rheum, University of Florence, Firenze, Italy, 7Faculty of Internal Medicine, Ghent University, Ghent, Belgium, 8Ghent University, Gent, Belgium, 9Discipline of Medicine, University of Adelaide, Adelaide, Australia, 10Thomas Jefferson University, Philadelphia, PA, 11Jefferson Institute of Molecular Medicine and Scleroderma Center, Rheumatology Division, Department of Medicine, Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: The UCLA SCTC GIT 2.0 and NIH PROMIS GI Symptoms Scales are validated in scleroderma to assess patient-reported gastrointestinal (GI) involvement. We sought to…
  • Abstract Number: 1249 • 2017 ACR/ARHP Annual Meeting

    What Factors Predict Good Patient Experiences of Switching from Reference Etanercept (EnbrelTM) to an Etanercept Biosimilar (BenepaliTM) in a South West London General Hospital?

    Laura Attipoe, Samir Patel, Robin Birt, Jennifer Crooks and Antigoni Grigoriou, Rheumatology, Kingston Hospital, Kingston, London, England, Kingston, United Kingdom

    Background/Purpose: The introduction of biological (BG) drugs in the last 20 years has revolutionised the treatment of patients with inflammatory arthritis (IA). The development of…
  • Abstract Number: 1250 • 2017 ACR/ARHP Annual Meeting

    Outcomes in Real-World Patients with Early Aggressive Rheumatoid Arthritis

    Keith Knapp1,2, Eric Mueller1,2 and Gary Craig1,2, 1Arthritis Northwest PLLC., Spokane, WA, 2Discus Analytics LLC., Spokane, WA

    Background/Purpose: The window of opportunity to address early rheumatoid arthritis (RA) in patients (pts) is well documented. However early aggressive (agr) RA needs further study…
  • Abstract Number: 1251 • 2017 ACR/ARHP Annual Meeting

    Chinese Patient Reported Index with Rheumatoid Arthritis (CPRI-RA): Reliability, Validity and Agreement with DAS28 and HAQ

    Man Han1, Xun Gong1, Xiao-po Tang1, Hong-xiao Liu2, Jian Liu3, Xin-chang Wang4, Jun-li Zhang5, Shi Chen6, Qing-chun Huang7, Yong-fei Fang8, Qing-jun Wu9, Dong-yi He10, Zhen-bin Li11, Yue Wang12, Hong Jiang13, Ming-li Gao14, Wei Liu15, Ying Liu16, Ze-guang Li17, Zhong-wen Zhao18, Cheng-wu Wang19, Wei-chao Liu20, Hai-dong Wang21, Yu-qian Lou22, Qing-liang Meng23, Chong-jie Ruan24, Yan-ming Xie25 and Quan Jiang26, 1Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 2Department of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 3The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Heifei, China, 4Rheumatology, The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, China, 5Rheumatology, The Fifth Hospital of Xi’an City, Xi’an, China, 6Rheumatology, Peking University People's Hospital, Beijing, China, 7Rheumatology, Guangzhou Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China, 8Rheumatology, Southwest Hospital, Third Military Medical University, chongqing, China, 9Rheumatology, Peking Union Medical College Hospital, Beijing, China, 10Institute of Arthritis Research, Shanghai Academy of Chinese Medical Sciences, Guanghua Integrative Medicine Hospital, Shanghai, China, 11Rheumatology, Bethune international peace hospital, Shi jiazhuang, China, 12Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, China, 13Rheumatology, The Ninth People's Hospital of Chongqing City, Chongqing, China, 14Rheumatology, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China, 15Department of Rheumatology and Immunology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China, 16Rheumatology, The Affiliated Hospital of Shangdong University of Traditional Chinese Medicine, Qingdao, China, 17Rheumatology, The First Affiliated Hospital of Hei Longjiang University of Traditional Chinese Medicine, Ha Erbin, China, 18Rheumatology, The Second People's Hospital of Fujian Province, Fujian, China, 19Rheumatology, The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China, 20Rheumatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China, 21Rheumatology, Gansu Provincial Hospital of Traditional Chinese Medicine, Shanxi, China, 22Henan Rheumatism Hospital, Zhengzhou, China, 23Rheumatology, Henan Provincial Hospital of Traditional Chinese Medicine, Zhengzhou, China, 24Rheumatology and Pain Management Department, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China, 25Clinical Evaluation Center, China Academy of Chinese Medical Sciences, Beijing, China, 26Rheumatology Department, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China

    Background/Purpose: The use of patient reported outcomes(PROs) has become increasingly popular in the chronic disease management, disease monitoring and the assessment of drug efficacy. However,…
  • « Previous Page
  • 1
  • …
  • 1286
  • 1287
  • 1288
  • 1289
  • 1290
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology